KL was reported to be involved in the progression of a series of human cancers, including small cell lung cancer, breast cancer, hepatocellular carcinoma, ovarian cancer, and regulating tumorigenesis, proliferation, progression and resistance to traditional antitumor therapies [10–15]. The gene discussed is KL; the disease is cancer.